Skip to content
Biodatica
Start free

Investigator

Alfredo Andres Celedon

SCANOGEN, INC. · funded by NIAID

Companies
2

Resolved onto their grants.

Grants
5

Federal awards on file.

Non-dilutive funding
$4.8M

Summed across those awards.

First award
Jun 1, 2016

Latest Sep 17, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. SB1

    Bloodstream infection detection directly on whole blood

    $969k

    Sep 17, 2025NIAIDSCANOGEN, INC.NIH RePORTER · 11257571 (opens the source filing in a new tab)

  2. R44

    Highly Multiplexed Single Molecule Tethering

    $1000k

    Aug 17, 2023NIAIDSCANOGEN, INC.NIH RePORTER · 11139424 (opens the source filing in a new tab)

  3. R44

    Culture and amplification-free bacterial sepsis diagnosis

    $1.0M

    Jun 9, 2023NIAIDSCANOGEN, INC.NIH RePORTER · 11090450 (opens the source filing in a new tab)

  4. R01

    Rapid ID and AST Directly from Whole Blood Using Single Molecule Detection

    $797k

    Jan 30, 2023NIAIDSCANOGEN, INC.NIH RePORTER · 11249969 (opens the source filing in a new tab)

  5. R44

    Bloodstream infection detection directly on whole blood

    $1.0M

    Jun 1, 2016NIAIDSCANOGEN, INC.NIH RePORTER · 11140525 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources